4.7 Letter

Autologous CD33-CAR-T cells for treatment of relapsed/refractory acute myelogenous leukemia

Journal

LEUKEMIA
Volume 35, Issue 11, Pages 3282-3286

Publisher

SPRINGERNATURE
DOI: 10.1038/s41375-021-01232-2

Keywords

-

Funding

  1. Ziopharm

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available